The opportunity in biosimilars is here, one has to grab it: Debayan Ghosh, Epygen Biotech

In an interview with ET Now, Debayan Ghosh , Founder & President, Epygen Biotech , says in five years, biosimilars is going to throw up $60 billion in India alone. The world took notice of biosimilars when Biocon got that approval.

You can read more here: The opportunity in biosimilars is here, one has to grab it: Debayan Ghosh, Epygen Biotech